The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Aggressive vs. Conservative Phototherapy for Infants with Extremely Low Birth Weight
Open accessAbstract
BACKGROUND: It is unclear whether aggressive phototherapy to prevent neurotoxic effects of bilirubin benefits or harms infants with extremely low birth weight (1000 g or less). METHODS: We randomly assigned 1974 infants with extremely low birth weight at 12 to 36 hours of age to undergo either aggressive or conservative phototherapy. The primary outcome was a composite of death or neurodevelopmental impairment determined for 91% of the infants by investigators who were unaware of the treatment assignments. RESULTS: Aggressive phototherapy, as compared with conservative phototherapy, significantly reduced the mean peak serum bilirubin level (7.0 vs. 9.8 mg per deciliter [120 vs. 168 micromol per liter], P<0.01) but not the rate of the primary outcome (52% vs. 55%; relative risk, 0.94; 95% confidence interval [CI], 0.87 to 1.02; P=0.15). Aggressive phototherapy did reduce rates of neurodevelopmental impairment (26%, vs. 30% for conservative phototherapy; relative risk, 0.86; 95% CI, 0.74 to 0.99). Rates of death in the aggressive-phototherapy and conservative-phototherapy groups were 24% and 23%, respectively (relative risk, 1.05; 95% CI, 0.90 to 1.22). In preplanned subgroup analyses, the rates of death were 13% with aggressive phototherapy and 14% with conservative phototherapy for infants with a birth weight of 751 to 1000 g and 39% and 34%, respectively (relative risk, 1.13; 95% CI, 0.96 to 1.34), for infants with a birth weight of 501 to 750 g. CONCLUSIONS: Aggressive phototherapy did not significantly reduce the rate of death or neurodevelopmental impairment. The rate of neurodevelopmental impairment alone was significantly reduced with aggressive phototherapy. This reduction may be offset by an increase in mortality among infants weighing 501 to 750 g at birth. (ClinicalTrials.gov number, NCT00114543.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E., & Galuppi, B. (1997) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1997.tb07414.x · Cited by 6,721
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Statistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials
Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., & Drazen, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr077003 · Cited by 1,445
Users' guides to the medical literature : a manual for evidence-based clinical practice
Guyatt, G. H., Rennie, D., Meade, M. O., & Cook, D. J. (2002) · Cited by 1,196
Intensive Care for Extreme Prematurity — Moving beyond Gestational Age
Tyson, J. E., Parikh, N. A., Langer, J., Green, C., & Higgins, R. D. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa073059 · Cited by 986
Self-citationBerry, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1927 · Cited by 726
Spiegelhalter, D. J., Myles, J. P., Jones, D. R., & Abrams, K. R. (1999) · BMJ · doi:10.1136/bmj.319.7208.508 · Cited by 421
Vohr, B. R., Wright, L. L., Poole, W. K., McDonald, S. A., & for the NICHD Neonatal Research Network Follow-up Study (2005) · Pediatrics · doi:10.1542/peds.2004-2247 · Cited by 388
Self-citationHack, M., Wilson-Costello, D., Friedman, H., Taylor, G. H., Schluchter, M., & Fanaroff, A. A. (2000) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.154.7.725 · Cited by 358
Self-citationEffective care of the newborn infant
Sinclair, J. C., Bracken, M. B., & Silverman, W. A. (1992) · Oxford University Press eBooks · Cited by 328
Clinical trials and rare diseases: A way out of a conundrum
Lilford, R. J., Thornton, J. G., & Braunholtz, D. (1995) · BMJ · doi:10.1136/bmj.311.7020.1621 · Cited by 237
Bilirubin and ascorbate antioxidant activity in neonatal plasma
Gopinathan, V., Miller, N. J., Milner, A. D., & Rice-Evans, C. A. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00666-0 · Cited by 208
Placing Trials in Context Using Bayesian Analysis
Brophy, J. M. (1995) · JAMA · doi:10.1001/jama.1995.03520350053028 · Cited by 154
Randomized Controlled Trials: Questions, Answers and Musings
Jadad, A. R., & Enkin, M. W. (2007) · Medical Entomology and Zoology · Cited by 144
Dixon, D. O., & Simon, R. M. (1991) · Biometrics · doi:10.2307/2532645 · Cited by 139
The agonising negative trend in monitoring of clinical trials
DeMets, D. L., Pocock, S. J., & Julian, D. G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03464-9 · Cited by 126
Boggs, T. R., Hardy, J. B., & Frazier, T. M. (1967) · The Journal of Pediatrics · doi:10.1016/s0022-3476(67)80107-0 · Cited by 120
Neurodevelopmental Outcomes of Extremely Low Birth Weight Infants
Vohr, B. R., Wright, L., Poole, W. K., & McDonald, S. A. (2005) · Cited by 95
Self-citationBayesian subset analysis: application to studying treatment‐by‐gender interactions
Simon, R. M. (2002) · Statistics in Medicine · doi:10.1002/sim.1295 · Cited by 80
The Neurotoxicity of Bilirubin
Cashore, W. J. (1990) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30577-3 · Cited by 76
Unbound bilirubin associated with kernicterus: A historical approach
Ahlfors, C. E. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.108566 · Cited by 61
Thompson, B. (1994) · Cited by 22
A Bayesian model for evaluating specificity of treatment effects in clinical trials
Simon, R. M., Dixon, D. O., & Freidlin, B. (1995) · Cancer treatment and research · doi:10.1007/978-1-4615-2009-2_8 · Cited by 11
Cited by
Kaplan, M., Bromiker, R., & Hammerman, C. (2011) · Neonatology · doi:10.1159/000330055 · Cited by 114
Metadata
- Authors
- Morris, B. H., Oh, W., Tyson, J. E., Stevenson, D. K., Phelps, D. L., O'Shea, T. M., McDavid, G. E., Perritt, R. L., Van Meurs, K. P., Vohr, B. R., Grisby, C., Yao, Q., Pedroza, C., Das, A., Poole, W. K., Carlo, W. A., Duara, S., Laptook, A. R., Salhab, W. A., Shankaran, S., Poindexter, B. B., Fanaroff, A. A., Walsh, M. C., Rasmussen, M. R., Stoll, B. J., Cotten, C. M., Donovan, E. F., Ehrenkranz, R. A., Guillet, R., & Higgins, R. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-30
- Volume
- 359
- Issue
- 18
- Pages
- 1885-1896
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1976451021
- Cited by
- 259
- References
- 23
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.